Trending Stock News

As Bristol Myers Squibb (BMY) Stock Value Rose, Tower Bridge Advisors Has Decreased Position by $185.74 Million; Parnassus Investments Has Lowered Its Compass Minerals International (CMP) Position by $117.67 Million

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Tower Bridge Advisors decreased its stake in Bristol Myers Squibb (BMY) by 1.54% based on its latest 2017Q4 regulatory filing with the SEC. Tower Bridge Advisors sold 3,031 shares as the company’s stock rose 2.38% while stock markets declined. The institutional investor held 193,519 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $11.86 billion, down from 196,550 at the end of the previous reported quarter. Tower Bridge Advisors who had been investing in Bristol Myers Squibb for a number of months, seems to be less bullish one the $86.18 billion market cap company. The stock decreased 0.06% or $0.03 during the last trading session, reaching $52.71. About 6.44 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since May 21, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Parnassus Investments decreased its stake in Compass Minerals International Inc. (CMP) by 89.8% based on its latest 2017Q4 regulatory filing with the SEC. Parnassus Investments sold 1.63M shares as the company’s stock declined 13.99% with the market. The institutional investor held 185,653 shares of the basic industries company at the end of 2017Q4, valued at $13.41M, down from 1.82 million at the end of the previous reported quarter. Parnassus Investments who had been investing in Compass Minerals International Inc. for a number of months, seems to be less bullish one the $2.33 billion market cap company. The stock decreased 0.72% or $0.5 during the last trading session, reaching $68.7. About 264,204 shares traded. Compass Minerals International, Inc. (NYSE:CMP) has declined 10.14% since May 21, 2017 and is downtrending. It has underperformed by 21.69% the S&P500.

Since March 10, 2018, it had 1 insider purchase, and 4 insider sales for $137,806 activity. $41,424 worth of Compass Minerals International, Inc. (NYSE:CMP) was sold by Yoder Amy. The insider Standen James D. sold $21,871. Another trade for 1,572 shares valued at $99,366 was sold by Malecha Francis Joseph.

Investors sentiment decreased to 1.16 in Q4 2017. Its down 0.25, from 1.41 in 2017Q3. It dived, as 24 investors sold CMP shares while 93 reduced holdings. 53 funds opened positions while 83 raised stakes. 34.60 million shares or 4.79% less from 36.34 million shares in 2017Q3 were reported. State Board Of Administration Of Florida Retirement Sys reported 15,597 shares stake. Td Asset Inc holds 15,412 shares. 200 are held by Farmers Merchants. Lapides Asset Mngmt Limited Liability Corporation owns 51,800 shares for 0.81% of their portfolio. Blair William And Il reported 0% in Compass Minerals International, Inc. (NYSE:CMP). Legal & General Gp Plc owns 41,924 shares. Pacad Investment Ltd reported 300 shares. Kornitzer Mngmt Incorporated Ks owns 274,765 shares or 0.34% of their US portfolio. Teacher Retirement Of Texas owns 11,658 shares. Wills Finance Incorporated holds 0.32% or 6,280 shares in its portfolio. Axa owns 4,800 shares or 0% of their US portfolio. Da Davidson And Commerce has invested 0.03% in Compass Minerals International, Inc. (NYSE:CMP). Oregon Pub Employees Retirement Fund holds 12,469 shares. 270,061 were accumulated by Loomis Sayles And Comm L P. Ftb Advsr, Tennessee-based fund reported 175 shares.

Analysts await Compass Minerals International, Inc. (NYSE:CMP) to report earnings on August, 6. They expect $-0.14 EPS, up 26.32% or $0.05 from last year’s $-0.19 per share. After $0.37 actual EPS reported by Compass Minerals International, Inc. for the previous quarter, Wall Street now forecasts -137.84% negative EPS growth.

More important recent Compass Minerals International, Inc. (NYSE:CMP) news were published by: Seekingalpha.com which released: “Compass Minerals’ (CMP) CEO Fran Malecha on Q1 2018 Results – Earnings Call Transcript” on May 02, 2018, also Businesswire.com published article titled: “Compass Minerals Announces Labor Strike at Goderich, Ontario, Salt Mine”, Globenewswire.com published: “Factors of Influence in 2018, Key Indicators and Opportunity within Compass Minerals International, Consolidated …” on April 26, 2018. More interesting news about Compass Minerals International, Inc. (NYSE:CMP) was released by: Businesswire.com and their article: “Compass Minerals Declares Dividend” with publication date: April 29, 2018.

Among 9 analysts covering Compass Minerals (NYSE:CMP), 5 have Buy rating, 1 Sell and 3 Hold. Therefore 56% are positive. Compass Minerals had 25 analyst reports since August 14, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus on Thursday, July 13 with “Buy”. On Wednesday, March 30 the stock rating was downgraded by BB&T Capital to “Hold”. The rating was upgraded by J.P. Morgan to “Buy” on Monday, September 25. As per Tuesday, April 12, the company rating was maintained by JP Morgan. The firm earned “Buy” rating on Monday, October 2 by Monness Crespi & Hardt. On Thursday, July 6 the stock rating was maintained by BMO Capital Markets with “Hold”. The stock of Compass Minerals International, Inc. (NYSE:CMP) has “Overweight” rating given on Monday, September 25 by JP Morgan. On Thursday, August 17 the stock rating was maintained by Stifel Nicolaus with “Buy”. The firm earned “Hold” rating on Wednesday, August 9 by Credit Suisse. The firm earned “Sell” rating on Monday, December 21 by Monness Crespi & Hardt.

Parnassus Investments, which manages about $10.39 billion and $25.48 billion US Long portfolio, upped its stake in Mondelez International Inc. Class A (NASDAQ:MDLZ) by 47,505 shares to 11.70 million shares, valued at $500.89 million in 2017Q4, according to the filing. It also increased its holding in Expeditors International Of Washington Inc. (NASDAQ:EXPD) by 368,590 shares in the quarter, for a total of 1.25 million shares, and has risen its stake in First Horizon National Corp. (NYSE:FHN).

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Bizjournals.com which released: “How Bristol-Myers Squibb’s new Peninsula digs boost its battle to beat cancer” on May 01, 2018, also Seekingalpha.com with their article: “Don’t Buy L Brands – Cramer’s Lightning Round (5/15/18)” published on May 16, 2018, Benzinga.com published: “BMO Sees Balanced Risk-Reward In Bristol-Myers, Takes Neutral Position” on April 27, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Seekingalpha.com and their article: “Jounce down 32% premarket on announcement of trial data on lead candidate JTX-2011” published on May 17, 2018 as well as Benzinga.com‘s news article titled: “Uniqure Notches Bullish Initiation On Gene Therapy Prospects” with publication date: May 20, 2018.

Since December 12, 2017, it had 2 buys, and 1 insider sale for $163,963 activity. On Monday, April 30 Paliwal Dinesh C bought $249,948 worth of Bristol-Myers Squibb Company (NYSE:BMY) or 4,770 shares. Samuels Theodore R. II bought 4,000 shares worth $249,187.

Tower Bridge Advisors, which manages about $1.11 billion and $932.33 billion US Long portfolio, upped its stake in Automatic Data Proces (NASDAQ:ADP) by 791 shares to 26,656 shares, valued at $3.12 billion in 2017Q4, according to the filing. It also increased its holding in Glaxosmithkline Plc (NYSE:GSK) by 2,589 shares in the quarter, for a total of 24,523 shares, and has risen its stake in Medtronic Plc (NYSE:MDT).

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on July, 26. They expect $0.86 EPS, up 16.22% or $0.12 from last year’s $0.74 per share. BMY’s profit will be $1.41 billion for 15.32 P/E if the $0.86 EPS becomes a reality. After $0.94 actual EPS reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts -8.51% negative EPS growth.

Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.09, from 1.03 in 2017Q3. It fall, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Rhenman And Partners Asset Mgmt Ab holds 1.07% or 129,802 shares in its portfolio. Tt Intl holds 0.14% or 15,518 shares. Canal Insurance Com reported 175,000 shares. Avalon Asset Management Ltd Limited Liability Company has invested 1.8% in Bristol-Myers Squibb Company (NYSE:BMY). Sequoia Fin Advisors has 7,921 shares. Cypress Cap Limited (Wy) invested in 1,350 shares or 0.09% of the stock. Exxonmobil Invest Mngmt Inc Tx invested in 260,243 shares or 0.44% of the stock. Polaris Greystone Financial Group Inc Ltd Llc holds 1.56% in Bristol-Myers Squibb Company (NYSE:BMY) or 310,126 shares. Brown Brothers Harriman & accumulated 90,962 shares or 0.03% of the stock. Texas Yale Cap Corp accumulated 15,747 shares. Kepos Lp accumulated 36,456 shares or 0.2% of the stock. Opus Inv Mgmt has invested 0.48% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Valley National Advisers Inc, Pennsylvania-based fund reported 4,569 shares. Salzhauer Michael reported 2,788 shares or 0.07% of all its holdings. Dubuque Bancshares & Company has invested 0.09% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY).

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *